[Blood fatty acids in the development and correction of metabolic syndrome].

AIM to investigate the composition of plasma fatty acids (FA) and red blood cells and the level of eicosanoids in patients with metabolic syndrome (MS) and to assess whether metabolic disturbances may be corrected during a cycle use of an ω-3 polyunsaturated fatty acid (PUFA). SUBJECTS AND METHODS Examinations were made in 46 patients, including Group 1… CONTINUE READING